Lumacaftor/ivacaftor

Grey

Brand Name(s):Orkambi

Indication:Cystic Fibrosis in people 12 years and older who are homozygous for the F508del mutation.

Rationale:1

Considered:Jul-16

Review Date:Jul-21

Comments:
NICE TA 398
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation
July 2016